Skip to content
by Legal Desire
2 July 2026

Baker McKenzie Advises on Memo Therapeutics’ Sale to Ipsen and Related Carve-Out

Advising firms

Deal team

16 lawyers named
LawyerFirmSeniorityPracticeOffice
Matthias Trautmann Lead Baker McKenzie Partner M&A Not stated
Julia Schieber Lead Baker McKenzie Partner life sciences Not stated
Benedikt Rutscheidt Baker McKenzie Senior associate M&A Not stated
Hesam Mirzai Baker McKenzie Senior associate M&A Not stated
Laksanaporn (Namfon) Chaiyakam Baker McKenzie Associate M&A Not stated
Daniel Jurcevic Baker McKenzie Associate M&A Not stated
Natalie Meier Baker McKenzie Other M&A Not stated
Johanna Moesch Baker McKenzie Partner data protection Not stated
Christoph Stutz Baker McKenzie Partner employment Not stated
Andreas Becker Baker McKenzie Associate employment Not stated
Elena Mani Solanes Baker McKenzie Associate IP Not stated
Benjamin Wipfler Baker McKenzie Trainee Not stated Not stated
Grégory Sarbach Baker McKenzie Trainee Not stated Not stated
Aleksandra Marchewka Baker McKenzie Trainee Not stated Not stated
Lukas Bader Baker McKenzie Trainee Not stated Not stated
Helena Regli Baker McKenzie Trainee Not stated Not stated

13 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
EUR 700m (EUR 700 million)
What the figure measures
Total transaction value
Client
Memo Therapeutics AGSell-side
Counterparties
Ipsen (Buy-side)